A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease

Nature Clinical Practice Neurology

Volumn 3, Issue 9, 2007, Pages 526-530

  Ho, Bryan ^a   Prakash, Rajan ^a   Morgan, John C ^a   Sethi, Kapil D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; LEVODOPA; ROPINIROLE;

ADULT; ARTICLE; CAMPTOCORMIA; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DYSKINESIA; ELECTROMYOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NEUROMUSCULAR DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; VIDEORECORDING;

DIAGNOSIS, DIFFERENTIAL; DYSTONIA; GAIT DISORDERS, NEUROLOGIC; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 34548473824     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0584     Document Type: Article

References (17)

1. Albanese A (2003) Diagnostic criteria for Parkinson's disease. Neurol Sci 24 (Suppl 1): S23-S26
2. Paulson H and Stern M (2004) Clinical manifestations of Parkinson's disease. In Movement Disorders: Neurologic Principles and Practice edn 2, 233-246 (Eds Watts RL and Koller WC) New York: McGraw-Hill
3. Lepoutre AC et al. (2006) A specific clinical pattern of camptocormia in Parkinson's disease. J Neurol Neurosurg Psychiatry 77: 1229-1234
4. Azher SN and Jankovic J (2005) Camptocormia: Pathogenesis, classification, and response to therapy. Neurology 65: 355-359
5. Djaldetti R et al. (1999) Camptocormia (bent spine) in patients with Parkinson's disease-characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 14: 443-447
6. Melamed E and Djaldetti R (2006) Camptocormia in Parkinson's disease. J Neurol 253 (Suppi 7): Svii14-Svii16
7. Sethi K (2003) Differential diagnosis of Parkinson's disease. In Handbook of Parkinson's Disease, edn 3, 43-70 (Eds Pahwa R et al. New York: Marcel Dekker
8. Van Gerpen A (2001) Camptocormia secondary to early amyotrophic lateral sclerosis. Mov Disord 16: 358-360
9. Zwecker M et al. (1998) Camptocormia: A case of possible paraneoplastic aetiology. Clin Rehabil 12: 157-160
10. Kiuru Sand livanainen M (1987) Camptocormia, a new side effect of sodium valproate. Epilepsy Res 1: 254-257
11. Schabitz WR et al. (2003) Severe forward flexion of the trunk in Parkinson's disease: Focal myopathy of the paraspinal muscles mimicking camptocormia. Mov Disord 18: 408-441
12. Horstink M et al. (2006) Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part 1: Early (uncomplicated) Parkinson's disease. Eur J Neurol 13: 1170-1185
13. Watts RL et al. (2007) Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology 68 272-276
14. Lang AE et al. (2006) Deep brain stimulation: Preoperative issues. Mov Disord 21 (Suppi 14): S171 -S196
15. Yamada K et al. (2006) Alleviation of camptocormia by bilateral subthalamic stimulation in a patient with Parkinson's disease. Parkinsonism Relat Disord 12: 372-375
16. Hellmann H et al. (2006) Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease. Mov Disord 21: 2008-2010
17. Micheli F et al. (2005) Camptocormia in a patient with Parkinson disease: Beneficial effects of pallidal deep brain stimulation. Case report. J Neurosurg 103: 1081-1083